US Stem Cell Inc (USRM)

[Tfan15]

I have also hoped, if there were to be a merger in Bioheart's future, for J&J to be the partner. There are several connections that could provide incentive to do so:
1. Mr. Murphy, his past success with Cordis alone would be an important benefit
2. MyoStar catheter being utilized in several of the clinical trials
3. J&J's business model allows for incoming companies to retain their autonomy...in my opinion, Mr. Tomas should always remain on the management team as his quality leadership and expertise are unrivaled
4. J&J is in need of a quality flagship business in the biopharmaceutical/pharma sector...Bioheart would be an amazing addition to what they already do have, and fill a current void

This is conjecture on my part, and certainly only an opinion, but if Bioheart were to merge with, or be acquired by another entity, this would be an amazing opportunity for all involved.